BioNTech SE (BNTX) Enterprise Value (2018 - 2025)
BioNTech SE (BNTX) posted Enterprise Value of -$18.4 billion for Q4 2025, down 8.3% sequentially from -$17.0 billion in Q3 2025, and up 5.67% YoY from -$17.4 billion in Q4 2024.
BioNTech SE (BNTX) Enterprise Value (2018 - 2025) Analysis & Trends
BioNTech SE has reported Enterprise Value for 8 years, with the latest figure at -$18.4 billion in Q4 2025.
- Quarterly Enterprise Value rose 5.67% year-over-year to -$18.4 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$18.4 billion (up 5.67% YoY) and the FY2025 annual result came in at -$17.9 billion, up 8.44% from the prior year.
- Enterprise Value slipped to -$18.4 billion in Q4 2025 per BNTX's latest filing, from -$17.0 billion in the prior quarter.
- Over five years, Enterprise Value peaked at -$432.8 million in Q3 2021 and troughed at -$19.5 billion in Q4 2024.
- A 5-year average of -$12.1 billion and a median of -$15.4 billion in 2025 frame the typical range for Enterprise Value.
- The widest YoY moves for Enterprise Value: up 15.45% in 2022, down 3039.57% in 2022.
- Over 5 years, Enterprise Value stood at -$2.4 billion in 2021, then slumped by 504.7% to -$14.3 billion in 2022, then decreased by 24.09% to -$17.8 billion in 2023, then dropped by 9.51% to -$19.5 billion in 2024, then advanced by 5.67% to -$18.4 billion in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$18.4 billion, -$17.0 billion, and -$15.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | -18.39 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.32 Bn |
| Sep 30, 2025 | -16.98 Bn |
| Jun 30, 2025 | -15.89 Bn |
| Mar 31, 2025 | -14.84 Bn |
| Dec 31, 2024 | -17.93 Bn |
| Sep 30, 2024 | -18.35 Bn |
| Jun 30, 2024 | -18.63 Bn |
| Mar 31, 2024 | -17.02 Bn |
| Dec 31, 2023 | -17.81 Bn |
| Sep 30, 2023 | -17.14 Bn |
| Jun 30, 2023 | -16.94 Bn |
| Mar 31, 2023 | -13.59 Bn |
| Dec 31, 2022 | -14.35 Bn |
| Sep 30, 2022 | -1.33 Bn |
| Jun 30, 2022 | -1.49 Bn |
| Mar 31, 2022 | -1.96 Bn |
| Dec 31, 2021 | -2.37 Bn |
| Sep 30, 2021 | -432.80 Mn |
| Jun 30, 2021 | -1.76 Bn |
| Mar 31, 2021 | -920.96 Mn |